Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.
Expect volatility as short-term risk of global recession remains. Growth is slowing (stagflation) while inflation rises and rising dollar (expected to rise further) putting pressure on emerging markets. High global debt, commodity prices rising, supply shortages, Russia...what a mess.
Expecting possible further downside here in short-term. Will look to add in 8p range. Might put some profit in Tesla on the dip as a hedge after it drops further too. If you compare the chart with bitcoin it looks eerily similar at the moment- weird. Don't expect it to play out but possible Head and Shoulders pattern?
https://stockcharts.com/h-sc/ui?s=SEE.L
https://bitcointreasuries.org
Sorry if link already posted.
Interesting BTC holdings valuations:
Argo $10.8 million (=£7.8 million),
Riot $60.8 million (=£43.7 million),
Hut 8 $147.7 million (=£106 million),
Mara $249 million (=£178.8 million)
Possible Head & Shoulders pattern forming in BTC chart (bearish)
- (hopefully not)
together with rising VIX price = Volatility
As far as bitcoin price, i think it will retrace to the 21 ema (atm ~44k) ..just not sure when. Obv if bitcoin rises the 21 ema rises too but it does retrace to this at some point. Also regulation news being good/bad will obv have an effect.
Missed this bit.
Mike Edwards, the Company's former Executive Chairman, retains the 7,047,525 options over Ordinary Shares granted to Mr Edwards in July 2018, and which have already vested, for a period of three years from January 27, 2020. The remaining 3,281,500 unvested options lapsed on his departure, and were returned to the option pool under the Company's 2018 option plan. Details of the Company's option plan are set out in the Company's prospectus dated 30 July 2018. The options granted to Mr Edwards remain exercisable at a price of 16 pence per Ordinary Share.
https://www.lse.co.uk/rns/ARB/grant-of-share-options-dbk3wam38tiia70.html
Argo, the leading cryptocurrency miner based in the UK (LSE:ARB), announces that the Board has granted an award of 11,400,000 options over ordinary shares of £0.001 each in the Company (Ordinary Shares).
These options have been granted to the Company's management, executive and Board members as a long term incentive. These options have been granted from the pool of available options established under the Company's 2018 option plan, including lapsed options that were returned to the Company's option pool.
The options are priced at £0.07 per Ordinary Share, and will begin to vest three months after the date of the grant in equal monthly tranches over the next 21 months and are exercisable on or before February 4, 2030.
++++++++++++++++++++++++
From chart it would seem sp ~6.7p at time of share options grant in Feb 2020 (i think).
Hard to believe target only 7p?
Why?
I wish our CEO would strategically take some money out of his wallet and buy some shares. :)
S7eve083, agreed. I don't buy this Aussie way mentality although I think it was the last CEO who said this.
I think if SEE RNS 5 billion km of data then sorry but to me this gives credence to Safestocks article. They already RNS'd 2 billion km (didn't they?). Safestocks was overly positive in the past imv and as the board had been quick to point out then 'not yet wrong' or along these lines...
That was before COVID redindi. Haven't heard him say funded to profit since and why not buy shares @ ~2p if so? (other co's BOD where doing it during the pandemic)
I'm not the only one who thinks Toyota will go in-house. I definitely read other posters view the same opinion.
So much for balance on the board. I almost give up.
Al Pacino, Forget about it.
Been here for ~2yrs (i think) and new to investing at the time. Sitting on loss currently % wise (on paper anyway) after listening to the rampers on the board. Apologies, maybe rampers isn't fair - overly positive maybe? The £3 group prediction which went on not so long ago (#team300) was ridiculous imv - atleast they've stopped for now.
In anycase it's money i can afford to lose - 1st rule of investing!
Albeit alot of SEE's downfall is due to the fleet debacle and not anyone here but the OP are dangerous imv esp to new investors.
I remember Alex8 warning of the bubble and being shouted down. We had Baxter moaning at the sp which was annoying. I include Safestocks in that group but at least he has posted some honest opinion of late.
Like some others on the board I am less optimistic on a Toyota deal. My thoughts (like others) are they will use an in-house solution or work with Denso. Paul has been quiet in re: Japan (just by opinion). Maybe wrong but weren't Toyota the first OEM to introduce a DMS to the market? Not confident on Volvo either but the rest up for grabs hopefully.
I do believe SEE will need a fund raise to profitability, sorry. They were confident in reaching 27000 installs in fleet but then COVID struck. They just haven't had much luck.
Will average down the day the CEO (or the BOD) buys some shares. Still really bothers me. The sp was ~2p for a while there and still they never bought, wtf. Whatever happened to Eyetracking? Wonder if KK (last CEO) sold his shares?
I would never tell anyone to buy or sell and would simply say hold if you are sitting on a loss and only invest what you can afford to lose and be careful newbies. GLA .
p.s. don't forget to diversify your pf.
p.s.s. Just read Coldfishpie post before posting. Made me laugh. Sorry but to some extent I agree with his posts. Don't think they will go bankrupt Coldfish. LO will continue to fund them - like Nanoco, just hope it turns out better..
Wondering if Redmile or Sofinnova will covert some/all of their $29million loan notes? Maybe sell a few shares once converted for a quick 4-5x profit from 15.5p conversion? Just a thought.
https://www.lse.co.uk/rns/REDX/proposed-financing-of-30m-and-notice-of-gm-ujfry3sr1vuwe61.html
Thought this was interesting. SWIR CMOS sensor using nanotechnology. I guess without need for QD's although doesn't say either way (I would imagine they would state if so?).
Competing tech to ST+Nano collab?
'InGaAs-based SWIR cameras have been around for decades, serving the science, aerospace, and defense industries, but have not been used for mass-market applications due to their high costs and large form factor. Based on a decade of nanophotonics research, TriEye enables the fabrication of a CMOS-based HD SWIR sensor at scale, which is small size and 1000x lower cost than current technology.'
https://www.greencarcongress.com/2020/06/20200611-trieye.html
Agreed Bonzoful and Nanonano.
Deal maybe less likely (although not impossible) as Nanoco and Samsung have had many months to settle and even if Merck decide to renew license at reduced expense, still see funding gap without deals.
Merck license ended 30 June 2020 (I think, see 25th March RNS) so overdue?
Does anyone have a link to where M.E. says he was confident on renewal of license with Merck? (maybe missed this although he has been "confident" on a lot of things)
My feeling (probably wrong) is aside from Samsung no-one else has use for Nano's QD's in display hence no interest from Chinese in FSP.
In the recent video CEO Michael Laurier said 'you can't do proper trials and tests unless you have proper FDA compliance' and 'what we are doing now is to get those larger trials moving'. Finally 'We hope to update the market in the coming months!'
My guess no news for 2-3 months. Just a hunch!
Being ramped here imv. New contracts will take time. Don't forget - results due soon will be below market expectations and operating loss of approximately £0.5 million with FDA approval believe to have significant contribution to revenues in the Medium term!
MC now £42million. Just sayin' lol.
Read last trading update before investing.
DYOR
https://www.lse.co.uk/rns/SYM/trading-update-4efuxahzy9eauxp.html
JR, I think people are getting carried away esp with some wild figures. New contracts will take time I suspect. Results due soon will be below market expectations and operating loss of approximately £0.5 million with FDA approval believe to have significant contribution to revenues in the medium term! Will wait till after results announced. MC now £34million - rising too fast imv but GLA.
Read last trading update before investing. imo
DYOR
https://www.lse.co.uk/rns/SYM/trading-update-4efuxahzy9eauxp.html
Trading Update
Symphony Environmental Technologies Plc (AIM: SYM), a global specialist of technologies that enhance the properties of plastic and complementary non-plastic products by making them biodegradable or resistant to external factors, announces a trading update for the financial year ending 31 December 2019.
Revenues for the second half of 2019 are now expected to be not less than £4.1 million, broadly similar to the first half. Accordingly, revenues for the full year 2019 will be below market expectations resulting in an operating loss of approximately £0.5 million. We reported in our Interim Results on 27 September 2019 that sales in the first half had been impacted due to inventory adjustments by some of our customers as a result of legislative clarification in certain markets. These factors persisted throughout the second half, as both business drivers, legislation and enforcement activities regarding the manufacture of plastics, remain in a fluid period of change. Consequently, higher d2w purchases expected in Q4 2019 have been deferred and are now expected to be placed in Q1 2020.
Net cash and cash equivalents totalled £1.2 million as at 30 November 2019 (30 June 2019: net borrowings of £0.4 million).
Michael Laurier, CEO of Symphony stated: "As previously reported, we are uncertain as to the timing of when sales will increase, but we believe this will be in the short rather than longer-term. The global issue of how-to best deal with plastics is hotly debated and being resolved in different ways from country to country. The business environment that we are engaged in is complex but it continues to open many opportunities to the pipeline of technologies that we have developed. Whilst these factors have affected Symphony's financial results for the year ending 31 December 2019, the Board remains confident in delivering an improved financial performance going forward."
https://www.medicalacademic.co.za/news/roche-hosts-2019-ncov-diagnostic-training-session/
The 2019-nCoV (novel coronavirus) is a new coronavirus and there is limited sequence information available. Three assays have been developed by TIB Molbiol to detect the presence of the virus and Roche is rolling these out as part of its Rapid Response initiative.